Functionalization and solubilization of polycyclic aromatic compounds by sulfoniumization
Despite their unique physical properties and diverse applications in materials science, poor solubility of polycyclic aromatic hydrocarbons (PAHs) limits further fine-tuning and investigation of these systems. Herein, we report a sulfoniumization strategy to solubilize and functionalize a diverse range of PAHs in a one-step protocol using a triethylene glycol ether-substituted diaryl sulfoxide. While mono-sulfoniumization is generally observed, modification of the reaction conditions to favor bis-sulfoniumization is shown. The downstream applicability of the resulting PAH sulfonium salts is validated through a series of post-functionalization reactions that include C-C and C-heteroatom bond formation, while their application in annulative π-extension (APEX) is showcased by the synthesis of tetra-<i>tert</i>-butylquaterrylene from perylene. The red-shifted absorption and fluorescence, along with high water solubility of the PAH sulfonium salts, enable their application in bio-imaging, where they demonstrate selective mitochondrial staining without cytotoxicity.
Authors
- Kazuma Amaike (ORCID: https://orcid.org/0000-0002-7874-5235)
- Frank Glorius (ORCID: https://orcid.org/0000-0002-0648-956X)
- Hideto Ito (ORCID: https://orcid.org/0000-0002-4034-6247)
- Tsubasa Okumura
- Constantin G. Daniliuc (ORCID: https://orcid.org/0000-0002-6709-3673)
- Daisuke Shimizu (ORCID: https://orcid.org/0000-0002-7669-2838)
- Johannes E. Erchinger (ORCID: https://orcid.org/0000-0001-6544-7282)
- Kenichiro Itami (ORCID: https://orcid.org/0000-0001-5227-7894)
- K. Nakata
Institutions
- Pioneer (United States) (US)
- University of Münster (DE)
- Nagoya University (JP)
Publication Details
- Journal
- Chemical Science
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5sc01415h
- Citations
- 3
- Primary Topic
- Inorganic and Organometallic Chemistry
- Type
- article
- Field-Weighted Citation Impact
- 2.81
Funders
- Verband der Chemischen Industrie
- Deutsche Forschungsgemeinschaft
- Chugai Pharmaceutical